Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid‐associated thrombocytopenia-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid‐associated thrombocytopenia

Published:2022-07-27 Issue:12 Volume:47 Page:2041-2048
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Onita Tetsushu¹²^ORCID,Ishihara Noriyuki¹,Ikebuchi Amika¹,Yano Takahisa¹,Nishimura Nobuhiro³,Tamaki Hiroki¹,Ikawa Kazuro²^ORCID,Morikawa Norifumi²,Naora Kohji¹

Affiliation:

1. Department of Pharmacy Shimane University Hospital Izumo Japan

2. Department of Clinical Pharmacotherapy Hiroshima University Hiroshima Japan

3. School of Pharmacy at Fukuoka International University of Health and Welfare Fukuoka Japan

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13747

Reference36 articles.

1. "Treatment Guidelines for MRSA Infections ‐ 2019 Revision" by The Japanese Society for Chemotherapy and The Japanese Society for Infectious Diseases.

2. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects;Slatter JG;Drug Metab Dispos,2001

3. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

4. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction

5. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with Venous Thromboembolism: A Retrospective, Cross-Sectional Real-World Study;Clinical Interventions in Aging;2024-06

2. IN THE LITERATURE;Clinical Infectious Diseases;2024-01-15

3. Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2023-08-14